Fig. 4From: Identification of small molecules capable of enhancing viral membrane fusionAnalysis of hit compounds after 72 h of incubation. A–F The ability of the selected compounds to increase syncytia formation was tested with the BiMuC assay in Hek293T cells. Briefly, Hek293T cells were transfected with Jun plus SARS-CoV 2 S proteins and independently with Fos and human ACE2. After 24 h, samples were combined and treated with the appropriate compound at the indicated concentration or mock-treated for 72 h. The fluorescence percentages over the mock (DMSO) treated samples are represented. The average and standard deviation of at least three independent experiments are shown. Dots represent individual experiments. Based on a one-tailed homoscedastic t-test, statistical differences between compound and mock-treated samples were calculated. When differences are significant, the p-value is shownBack to article page